Market Analysis
Earnings Review: Medtronic Beats Expectations with 6% Increase in Revenue
Medtronic reported an EPS of $1.2, beating the expected $1.18. The firm's revenue grew by 6% in Q2 FY24.
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
Medtronic's fourth-quarter performance exceeded expectations, with notable growth in key segments.
Medtronic reported an EPS of $1.2, beating the expected $1.18. The firm's revenue grew by 6% in Q2 FY24.